SSR2-SUPT16H Fusion FISH Probe
The SSR2-SUPT16H Fusion FISH Probe is used to confirm a fusion of the SSR2 and SUPT16H genes. The fusion of the SSR2 and SUPT16H genes has been associated with Stomach Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SSR2-SUPT16H-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SSR2-SUPT16H-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SSR2-SUPT16H-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SSR2-SUPT16H-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SSR2-SUPT16H-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SSR2-SUPT16H-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SSR2-SUPT16H-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SSR2-SUPT16H-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SSR2-SUPT16H-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SSR2-SUPT16H-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SSR2-SUPT16H-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SSR2-SUPT16H-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SSR2-SUPT16H-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SSR2-SUPT16H-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SSR2-SUPT16H-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SSR2-SUPT16H-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SSR2-SUPT16H-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SSR2-SUPT16H-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SSR2-SUPT16H-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SSR2-SUPT16H-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SSR2-SUPT16H-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SSR2-SUPT16H-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SSR2-SUPT16H-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SSR2-SUPT16H-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SSR2-SUPT16H-20-AQAQ | 20 (40 μL) | 200 μL |
|
SSR2 Gene Summary
The signal sequence receptor (SSR) is a glycosylated endoplasmic reticulum (ER) membrane receptor associated with protein translocation across the ER membrane. The SSR consists of 2 subunits, a 34-kD glycoprotein (alpha-SSR or SSR1) and a 22-kD glycoprotein (beta-SSR or SSR2). The human beta-signal sequence receptor gene (SSR2) maps to chromosome bands 1q21-q23. [provided by RefSeq, Jul 2008]
Gene Name: Signal Sequence Receptor Subunit 2
Chromosome: CHR1: 155978838 -155990758
Locus: 1q22
SUPT16H Gene Summary
Transcription of protein-coding genes can be reconstituted on naked DNA with only the general transcription factors and RNA polymerase II. However, this minimal system cannot transcribe DNA packaged into chromatin, indicating that accessory factors may facilitate access to DNA. One such factor, FACT (facilitates chromatin transcription), interacts specifically with histones H2A/H2B to effect nucleosome disassembly and transcription elongation. FACT is composed of an 80 kDa subunit and a 140 kDa subunit; this gene encodes the 140 kDa subunit. [provided by RefSeq, Feb 2009]
Gene Name: SPT16 Homolog, Facilitates Chromatin Remodeling Subunit
Chromosome: CHR14: 21819630 -21852425
Locus: 14q11.2
Gene Diseases
The SSR2 SUPT16H Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Stomach Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|